Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Martin I de Bock"'
Autor:
Oscar T Sergel-Stringer, Hesham S Al-Sallami, Sara E Styles, Alisa Boucsein, Martin I de Bock, Benjamin J Wheeler
Publikováno v:
BMC Endocrine Disorders, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Purpose To explore the lived experiences of alcohol consumption among young adults with type 1 diabetes. Methods Fourteen semi-structured interviews were conducted amongst young adults aged between 18 and 25 years, inclusive, with type 1 dia
Externí odkaz:
https://doaj.org/article/233be220eb6e45259acf2e54afc5b713
Autor:
Mercedes J. Burnside, Jonathan A. Williman, Hannah M. Davies, Craig A. Jefferies, Ryan G. Paul, Benjamin J. Wheeler, Esko J. Wiltshire, Yvonne C. Anderson, Martin I. de Bock
Publikováno v:
The Lancet Regional Health. Western Pacific, Vol 31, Iss , Pp 100644- (2023)
Summary: Background: Continuous glucose monitoring (CGM) improves glycaemia for people affected by type 1 diabetes (T1D), but is not funded in Aotearoa/New Zealand. This study explores the impact of non-funded CGM on equity of access and associated g
Externí odkaz:
https://doaj.org/article/63bfb9b2eb994c318b883013ba4f2b0e
Autor:
Mercedes J. Burnside, Dana M. Lewis, Hamish R. Crocket, Renee A. Meier, Jonathan A. Williman, Olivia J. Sanders, Craig A. Jefferies, Ann M. Faherty, Ryan G. Paul, Claire S. Lever, Sarah K.J. Price, Carla M. Frewen, Shirley D. Jones, Tim C. Gunn, Christina Lampey, Benjamin J. Wheeler, Martin I. de Bock
Publikováno v:
Diabetes Technology & Therapeutics. 25:250-259
Autor:
Alisa Boucsein, Antony S. Watson, Carla M. Frewen, Olivia J. Sanders, Jillian J. Haszard, Shirley D. Jones, Philippa J. Milford-Hughes, Martin I. de Bock, Benjamin J. Wheeler
Publikováno v:
Diabetes Care. 46:628-632
OBJECTIVETo evaluate glycemic outcomes in youth (aged 13–25 years) with type 1 diabetes and high-risk glycemic control (HbA1c ≥8.5% [69 mmol/mol]) on multiple daily injection (MDI) therapy after transitioning to advanced hybrid closed loop (AHCL)
Autor:
Mercedes J. Burnside, Dana M. Lewis, Hamish R. Crocket, Renee A. Meier, Jonathan A. Williman, Olivia J. Sanders, Craig A. Jefferies, Ann M. Faherty, Ryan G. Paul, Claire S. Lever, Sarah K.J. Price, Carla M. Frewen, Shirley D. Jones, Tim C. Gunn, Christina Lampey, Benjamin J. Wheeler, Martin I. de Bock
Publikováno v:
New England Journal of Medicine. 387:869-881
Open-source automated insulin delivery (AID) systems are used by many patients with type 1 diabetes. Data are needed on the efficacy and safety of an open-source AID system.In this multicenter, open-label, randomized, controlled trial, we assigned pa
Autor:
Shelley Rose, Jillian J. Haszard, Barbara C. Galland, Esko J. Wiltshire, Martin I. de Bock, Carmel E. Smart, Miriama Ketu-McKenzie, Anna Campbell, Ruth Thomson, Craig A. Jefferies, Benjamin J. Wheeler, Sara E. Styles
Publikováno v:
Journal of Diabetes & Metabolic Disorders. 21:2023-2033
Purpose The OPTIMISE study uses a Multiphase Optimisation Strategy (MOST) to identify the best combination of four interventions targeting key diabetes self-care behaviours for use in clinical practice to improve short-term glycaemic outcomes. Method
Publikováno v:
NSNZ 2022.
Autor:
Benjamin J. Wheeler, Martin I. de Bock, Philippa J. Milford-Hughes, Shirley D. Jones, Jillian J. Haszard, Olivia J. Sanders, Carla M Frewen, Antony S. Watson, Alisa Boucsein
Objective: To evaluate glycemic outcomes in youth (aged 13–25 years) with type 1 diabetes and high-risk glycemic control [HbA1c ≥ 8.5% (69 mmol/mol)] on multiple daily injections (MDI) after transitioning to advanced hybrid closed-loop (AHCL) the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62b8c5df66bb8ba64b8af7ded1daf23a
https://doi.org/10.2337/figshare.21785207
https://doi.org/10.2337/figshare.21785207
Autor:
Shelley Rose, Barbara C. Galland, Sara E. Styles, Esko J. Wiltshire, James Stanley, Martin I. de Bock, Paul A. Tomlinson, Jenny A. Rayns, Benjamin J. Wheeler
Publikováno v:
Pediatric Diabetes.
Background. The bidirectional relationship between sleep and blood glucose levels may particularly affect adolescents and young adults (AYA), who are more likely to experience less healthy glycemic outcomes and more disrupted sleep patterns. To date,
Autor:
Mercedes J. Burnside, Jonathan A. Williman, Hannah M. Davies, Craig A. Jefferies, Ryan G. Paul, Benjamin J. Wheeler, Esko J. Wiltshire, Yvonne C. Anderson, Martin I. de Bock
Publikováno v:
The Lancet regional health. Western Pacific. 31
Continuous glucose monitoring (CGM) improves glycaemia for people affected by type 1 diabetes (T1D), but is not funded in Aotearoa/New Zealand. This study explores the impact of non-funded CGM on equity of access and associated glycaemic outcomes.Cro